Sponsored Research
Pamela S. Douglas of Cardiology has received an award from the American Heart Association for a project entitled "Douglas AHA Early Career Mentorship." Total funding will be $44,963.
Michael D. Gunn of Cardiology has received an award (1R21-AI128405-01) from the National Institutes of Health for a project entitled "Generation of Zika virus-specific recombinant antibodies." Total funding will be $437,250.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "TO#4 CC Leadership." Total funding will be $987,128.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 6: Strategic Planning and Sustainability." Total funding will be $366,446.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 3: IRB Workplan & Implementation." Total funding will be $183,651.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 2: PMO Workplan and Implementation." Total funding will be $2,782,903.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 1: CC Phase II Master Contract Leadership." Total funding will be $2,932,990.
Christopher Kontos of Cardiology has received an award (3R01-HL124444-01S1) from the National Institutes of Health for a project entitled "Skeletal Muscle and Vascular Remodeling in Peripheral Artery Disease." Total funding will be $140,313.
Ann M. Navar-Boggan of Cardiology has received an award (1K01-HL133416-01) from the National Institutes of Health for a project entitled "Preventing Cardiovascular Disease through Improved Risk Prediction and Communication." Total funding will be $706,667.
Eric D. Peterson of Cardiology has received an award from the American College of Cardiology Foundation for a project entitled "TVT Registry Analytic Center Amendment 6." Total funding will be $3,778,582.
David D'Alessio of Endocrinology, Metabolism, and Nutrition has received a sub-award (R01-DK076092-09) through the Tufts Medical Center for a project entitled "The Role of Vitamin D in Established Type 2 Diabetes." Total funding will be $29,315.
Richard H. Lee of Endocrinology, Metabolism, and Nutrition has received an award from the American Diabetes Association for a project entitled "TFWS/GEMSSTAR Professional Development Plan." Total funding will be $50,000.
Leigh Boulware of General Internal Medicine has received an award from the National Institutes of Health for a project entitled "Bruce Burnett IPA." Total funding will be $185,776.
Cathleen S. Colon-Emeric of Geriatrics has received an award (2P30-AG028716-11) from the National Institutes of Health for a project entitled "Research Education Component (REC)", a part of Kenneth E. Schmader's project entitled "Duke Claude D. Pepper Older Americans Independence Center." Total funding will be $140,940.
Miriam C. Morey of Geriatrics has received an award (2P30-AG028716-11) from the National Institutes of Health for a project entitled "Research Core 2: Physical Measurements Core (RC2)", a part of Kenneth E. Schmader's project entitled "Duke Claude D. Pepper Older Americans Independence Center." Total funding will be $214,650.
Kenneth E. Schmader of Geriatrics has received an award (2P30-AG028716-11) from the National Institutes of Health for a project entitled "Leadership and Administrative Core (LAC)." Total funding will be $182,850.
Heather E. Whitson of Geriatrics has received an award (2P30-AG028716-11) from the National Institutes of Health for a project entitled "Pilot/Exploratory Studies Core (PESC)", a part of Kenneth E. Schmader's project entitled "Duke Claude D. Pepper Older Americans Independence Center." Total funding will be $77,470.
Jun Chen of Hematological Malignancies and Cellular Therapy has received an award (HHSN272201400034C-Mod04) from the Department of Health and Human Services for a project entitled "Advanced Development of Medical Countermeasures to Enhance Platelet Regeneration." Total funding will be $289,982.
Cristina Gasparetto of Hematological Malignancies and Cellular Therapy has received an award through Oregon Health & Science University for a project entitled "A Feasibility Phase II study of BEAM followed by MLN 9708 Maintenance therapy in high risk MM patients." Total funding will be $163,983.
Vivian H. Chu of Infectious Diseases has received an award (1R34-AI122958-01) from the National Institutes of Health for a project entitled "Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin." Total funding will be $238,500.
Jeffrey M. Clarke of Medical Oncology has received an award from the Lung Cancer Initiative of North Carolina for a project entitled "Evaluation of Tumor Infiltrating Lymphocytes in Resected Non-Small Cell Lung Cancer." Total funding will be $25,000.
Allison E. Ashley-Koch of Nephrology has received an award (1R01-DK110104-01) from the National Institutes of Health for a project entitled "Transcriptomic, therapeutic and genetic investigations of sickle cell nephropathy." Total funding will be $715,500.
Gentzon Hall of Nephrology has received an award from the American Society of Nephrology for a project entitled "Novel Gene Discovery in African Americans with Hereditary Focal Segmental Glomerulosclerosis." Total funding will be $105,000.
Lesley H. Curtis of Medicine has received a sub-award through Harvard Pilgrim Health Care, Inc. for a project entitled "Duke Clinical Research Institute (DCRI) - Center for Medicare & Medicaid Services (CMS) Data Partner." Total funding will be $156,624.
Lesley H. Curtis of Medicine has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 11: Query Fulfillment Workplan and Implementation." Total funding will be $2,585,163.
Lesley H. Curtis of Medicine has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 10: Analytic Tools Workplan and Implementation." Total funding will be $2,494,855.
Lesley H. Curtis of Medicine has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 9: DRN OC Data Characterization & Liaison Workplan and Implementation." Total funding will be $3,386,508.
Lesley H. Curtis of Medicine has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Task Order 8: DRN OC Workplan and Implementation." Total funding will be $3,806,502.
David M. Brass of Pulmonary, Allergy, and Critical Care Medicine has received an award from the Centers for Disease Control and Prevention for a project entitled "Spectrum of Flavoring Chemical-Related Lung Disease Task Order 1." Total funding will be $2,432.
Lake D. Morrison of Pulmonary, Allergy, and Critical Care Medicine has received an award from the Pulmonary Fibrosis Foundation for a project entitled "Care Center Network Charter Agreement." Total funding will be $7,500.
Scott M. Palmer of Pulmonary, Allergy, and Critical Care Medicine has received a sub-award (5U01-AI063594-12) through the Mount Sinai School of Medicine for a project entitled "CTOT Ancillary Studies Fund." Total funding will be $237,614.
Virginia B. Kraus of Rheumatology and Immunology has received an award (2P30-AG028716-11) from the National Institutes of Health for a project entitled "Research Core 1: Molecular Measures Core (RC1)", a part of Kenneth E. Schmader's project entitled "Duke Claude D. Pepper Older Americans Independence Center." Total funding will be $247,685.
E. William St Clair of Rheumatology and Immunology has received a sub-award (5UM1-AI109565-03) through the Benaroya Research Institute at Virginia Mason for a project entitled "Immune Tolerance Network (F.Nepom)-INT823ST/iWITH Autoantitbody Testing." Total funding will be $123,028.
Industry-sponsored Clinical Trials
Renato D. Lopes of Cardiology has received an award from Eli Lilly and Company for a project entitled "A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus." Total funding will be $158,246.
Manesh R. Patel of Cardiology has received an award from Cardiovascular Systems Inc. for a project entitled "CSI Educational Program Agreement VII." Total funding will be $17,365.
Thomas J. Povsic of Cardiology has received an award from GlaxoSmithKline for a project entitled "A Biomarker Study of the APEX-AMI and SOLSTICE Trial Populations." Total funding will be $537,568.
Sudarshan Rajagopal of Cardiology has received an award from Eiger BioPharmaceuticals, Inc. for a project entitled "A Phase 2, Open-Label, Extension Study to Evaluate the Long- Term Safety and Efficacy of Ubenimex in Patients with Pulmonary Arterial Hypertension (WHO Group 1)." Total funding will be $127,881.
Ziad F. Gellad of Gastroenterology has received an award from Sanofi US for a project entitled "EFC 13794." Total funding will be $171,363.
Cristina Gasparetto of Hematological Malignancies and Cellular Therapy has received an award from Karyopharm Therapeutics for a project entitled "Phase Ib/2 Study of Selinexor (KPT330) in combination with Backbone treatment for R/R Multiple Myeloma." Total funding will be $77,740.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from Daiichi Sankyo Inc for a project entitled "AC220-A-U302 trial." Total funding will be $2,236,887.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from Hybrigenics for a project entitled "Efficacy study of Inecalitol in combination with Decitabine in Acute Myeloid Patients unfit for standard chemotherapy." Total funding will be $151,389.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from Eureka Therapeutics, Inc. for a project entitled "Development of the Phase I study involving ET190L1-Artemis in CD19 positive blood malignancies." Total funding will be $5,001.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from Cantex Pharmaceuticals, Inc. for a project entitled "Randomized Phase II study of CX-01 combined with standard induction therapy for newly diagnosed AML." Total funding will be $257,382.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from Syros Pharmaceuticals for a project entitled "A Biomarker-Directed Phase 2 Trial of SY-1425, a Selective Retinoic Acid Receptor Alpha Agonist, in Adult Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)." Total funding will be $164,560.
Thomas L. Ortel of Hematology has received an award from Siemens Healthcare Diagnostics for a project entitled "External Evaluation of Assay Applications on The Sysmex CS2500 and CS-5100 Analyzer (Wave C)." Total funding will be $101,720.
Jeffrey M. Clarke of Medical Oncology has received an award from MedPacto, Inc for a project entitled "Blood-based Biomarker Profiling for TEW-7197." Total funding will be $44,700.
Richard F. Riedel of Medical Oncology has received an award from Karyopharm Therapeutics for a project entitled "A Phase 2-3, Multicenter, Randomized, Double-Blind Study of Selinexor (Kpt-330) Versus Placebo In Patients With Advanced Unresectable Dedifferentiated Liposarcoma (Ddls)." Total funding will be $308,999.
John H. Strickler of Medical Oncology has received an award from OncoMed Pharmaceuticals for a project entitled "A Phase 1a/b dose escalation study of the safety pharmacokinetics and pharmacodynamics of OMP-131-R10 in advanced solid tumors and in combination with FOLFIRI for patients with previously treated metastatic colorectal cancer." Total funding will be $260,505.
John H. Strickler of Medical Oncology has received an award from OncoMed Pharmaceuticals for a project entitled "Determine the tissue prevalence and molecular phenotype of Rspo3 gene fusions in patients with metastatic CRC and validate their predictive capacity in vivo." Total funding will be $337,080.
Gordana Vlahovic of Medical Oncology has received an award from Pfizer, Inc. for a project entitled "A Phase 1 Dose Escalation Study Evaluating the Safety and Tolerability of PF-06840003 in Patients with Malignant Glioma." Total funding will be $460,853.
Gordana Vlahovic of Medical Oncology has received an award from the Bristol-Myers Squibb Company for a project entitled "A randomized phase 2 single blind study of temozolomide plus radiation therapy combined with nivolumab or placebo in newly diagnosed adult subjects with MGMT-methylated glioblastoma (BMS CA209-548)." Total funding will be $238,963.
Alice L. Gray of Pulmonary, Allergy, and Critical Care Medicine has received an award from Proteostasis Therapeutics for a project entitled "A Multi-center, randomized, placebo controlled, ascending dose Phase I study designed to assess the safety, tolerability, and pharmacokinetics of PTI-428 in subjects with Cystic Fibrosis." Total funding will be $124,235.
Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "A randomized, double-blind, chronic dosing placebo-controlled, parallel group, multicenter, Phase III study to evaluate the efficacy and safety of 2 doses of benralizumab (MEDI-563) in patients with moderate to very severe COPD with a history of COPD." Total funding will be $186,105.
Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from Pearl Therapeutics, Inc for a project entitled "A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 compared to PT005 on COPD Exacerbations over a 52- Week Treatment Period in Subjects With Moderate to Very Severe COPD (Protocol No. PT009003)." Total funding will be $230,485.
Neil R. MacIntyre of Pulmonary, Allergy, and Critical Care Medicine has received an award from Teleflex, Inc. for a project entitled "Teleflex Educational Workshop." Total funding will be $23,760.
Lake D. Morrison of Pulmonary, Allergy, and Critical Care Medicine has received an award from Promedior, Inc for a project entitled "Promedior PRM-151." Total funding will be $153,742.
Ankoor Shah of Rheumatology and Immunology has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with `Systemic Sclerosis associated Interstitial Lung Disease'(SSc-ILD)." Total funding will be $175,558.